ORAL FORMULATIONS CONTAINING HYALURONIC ACID FOR SUSTAINED DRUG RELEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140302131A1
SERIAL NO

14342486

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses a tablet or a capsule for oral administration comprising 0.5-0% (w/w) hyaluronic acid or a salt thereof, an active pharmaceutical ingredient (API), and a coating.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVOZYMES BIOPHARMA DK A/S2880 BAGSVAERD

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dall, Ole Moeller Frederiksberg, DK 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation